Activation of Eosinophils Interacting with Dermal Fibroblasts by Pruritogenic Cytokine IL-31 and Alarmin IL-33: Implications in Atopic Dermatitis
暂无分享,去创建一个
C. Lam | C. Wong | A. Choi | H. Qiu | Joyce S W Chow | K. Leung | K. M. Leung | Huaina Qiu
[1] B. Lüscher,et al. IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis. , 2012, Acta dermato-venereologica.
[2] L. French,et al. Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection. , 2011, The Journal of allergy and clinical immunology.
[3] T. Werfel,et al. Functional effects of interleukin 31 in human primary keratinocytes , 2011, Allergy.
[4] H. Shimizu,et al. Macrophage migration inhibitory factor is essential for eosinophil recruitment in allergen-induced skin inflammation. , 2011, The Journal of investigative dermatology.
[5] Y. Gho,et al. Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammation , 2011, Allergy.
[6] R. Lafyatis,et al. dsRNA activation of endothelin-1 and markers of vascular activation in endothelial cells and fibroblasts , 2010, Annals of the rheumatic diseases.
[7] C. Lam,et al. Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis. , 2010, International immunology.
[8] I. McInnes,et al. Disease-associated functions of IL-33: the new kid in the IL-1 family , 2010, Nature Reviews Immunology.
[9] C. Wong,et al. Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation , 2010, Cellular and Molecular Immunology.
[10] Miran Kim,et al. IL-6, VEGF, KC and RANTES are a major cause of a high irritant dermatitis to phthalic anhydride in C57BL/6 inbred mice. , 2010, Allergology international : official journal of the Japanese Society of Allergology.
[11] R. Locksley,et al. IL‐18 and IL‐33 elicit Th2 cytokines from basophils via a MyD88‐ and p38α‐dependent pathway , 2009, Journal of leukocyte biology.
[12] F. Liew,et al. The cytokine interleukin-33 mediates anaphylactic shock , 2009, Proceedings of the National Academy of Sciences.
[13] C. Dahinden,et al. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. , 2009, Blood.
[14] K. Matsushima,et al. Anti‐interleukin‐31‐antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis , 2009, Experimental dermatology.
[15] M. Teixeira,et al. IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-41 , 2008, The Journal of Immunology.
[16] S. Ständer,et al. Correlation of IL-31 serum levels with severity of atopic dermatitis. , 2008, The Journal of allergy and clinical immunology.
[17] K. Huntoon,et al. Regulated expression of the IL-31 receptor in bronchial and alveolar epithelial cells, pulmonary fibroblasts, and pulmonary macrophages. , 2008, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[18] C. Wong,et al. Molecular Mechanisms of Cytokine and Chemokine Release from Eosinophils Activated by IL-17A, IL-17F, and IL-23: Implication for Th17 Lymphocytes-Mediated Allergic Inflammation , 2008, The Journal of Immunology.
[19] Songhee Jeon,et al. Impaired PI3K/Akt Activation-Mediated NF-κB Inactivation Under Elevated TNF-α Is More Vulnerable to Apoptosis in Vitiliginous Keratinocytes , 2007 .
[20] C. Wong,et al. Leptin‐mediated cytokine release and migration of eosinophils: Implications for immunopathophysiology of allergic inflammation , 2007, European journal of immunology.
[21] S. Watanabe,et al. Leukotriene B4 enhances tumour necrosis factor‐α‐induced CCL27 production in human keratinocytes , 2007 .
[22] C. Wong,et al. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. , 2007, American journal of respiratory cell and molecular biology.
[23] S. Rose-John,et al. Interleukin-31 and Oncostatin-M Mediate Distinct Signaling Reactions and Response Patterns in Lung Epithelial Cells* , 2007, Journal of Biological Chemistry.
[24] Songhee Jeon,et al. Impaired PI3K/Akt activation-mediated NF-kappaB inactivation under elevated TNF-alpha is more vulnerable to apoptosis in vitiliginous keratinocytes. , 2007, The Journal of investigative dermatology.
[25] S. Watanabe,et al. Leukotriene B(4) enhances tumour necrosis factor-alpha-induced CCL27 production in human keratinocytes. , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[26] C. Capristo,et al. Immune dysregulation in atopic dermatitis. , 2006, Allergy and asthma proceedings.
[27] W. Silny,et al. Selected eosinophil proteins as markers of inflammation in atopic dermatitis patients. , 2006, Acta dermatovenerologica Croatica : ADC.
[28] A. Bosio,et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. , 2006, The Journal of allergy and clinical immunology.
[29] M. Steinhoff,et al. Cytokines and chemokines orchestrate atopic skin inflammation. , 2006, The Journal of allergy and clinical immunology.
[30] S. Nakaike,et al. Involvement of IL‐31 on scratching behavior in NC/Nga mice with atopic‐like dermatitis , 2006, Experimental dermatology.
[31] M. Steinhoff,et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. , 2006, The Journal of allergy and clinical immunology.
[32] B. Harder,et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. , 2006, The Journal of allergy and clinical immunology.
[33] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[34] G. Girolomoni,et al. ERK1/2 Regulates Epidermal Chemokine Expression and Skin Inflammation1 , 2005, The Journal of Immunology.
[35] S. Chevalier,et al. Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling. , 2004, European cytokine network.
[36] P. Heinrich,et al. Characterization of the Signaling Capacities of the Novel gp130-like Cytokine Receptor* , 2004, Journal of Biological Chemistry.
[37] Scott R. Presnell,et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice , 2004, Nature Immunology.
[38] H. Simon,et al. Eosinophils and atopic dermatitis , 2004, Allergy.
[39] A. Wardlaw. Eosinophil trafficking: new answers to old questions , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[40] C. Wong,et al. Clinical applications of cytokine assays. , 2003, Advances in clinical chemistry.
[41] V. Rutten,et al. Immune dysregulation in atopic dermatitis. , 2002, Veterinary immunology and immunopathology.
[42] A. Kapp,et al. Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining , 2001, The British journal of dermatology.
[43] S. Taniuchi,et al. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein. , 2001, Journal of dermatological science.
[44] P. Conti,et al. MCP-1 and RANTES are mediators of acute and chronic inflammation. , 2001, Allergy and asthma proceedings.
[45] A. Zlotnik,et al. The biology of chemokines and their receptors. , 2000, Annual review of immunology.
[46] J. Schröder,et al. The Role of Chemokines in Cutaneous Allergic Inflammation , 1999, Biological chemistry.
[47] K. Nishioka. [Clinical practice of atopic dermatitis]. , 1997, Arerugi = [Allergy].
[48] P. Askenase,et al. Development of Atopic Dermatitis-like Skin Lesion with Ige Hyperproduction in Nc/nga Mice , 2022 .
[49] J. Hanifin,et al. Increased interleukin 6 production by T cells derived from patients with atopic dermatitis. , 1993, The Journal of investigative dermatology.
[50] P. Bruijnzeel,et al. The involvement of eosinophils in the patch test reaction to aeroallergens in atopic dermatitis: its relevance for the pathogenesis of atopic dermatitis , 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[51] D. C. Fournier,et al. Interleukin-6 is released in the cutaneous response to allergen challenge in atopic individuals. , 1992, The Journal of allergy and clinical immunology.
[52] M. Uehara,et al. Blood eosinophilia in atopic dermatitis , 1990, Clinical and experimental dermatology.
[53] C. Griffiths,et al. The role of adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin disease--1990 update. , 1990, The Journal of investigative dermatology.
[54] R. Larson,et al. Structure and Function of Leukocyte Integrins , 1990, Immunological reviews.